Drugs / Choline Bitartrate
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials · 1 met primary | ||||||
| Phase 2 | NCT05108974 | Oct 2021 → Jul 2027 expected | fetal alcohol spectrum disorder | Jeff Wozniak | Active not recruiting | No outcome recorded |
| Phase 2 | NCT02735473 | Jun 2016 → Sep 2021 | fetal alcohol spectrum disorder | University of Minnesota | Completed | Met primary |
| Phase not applicable1 trial | ||||||
| — | NCT04012177 | Jul 2019 → Sep 2022 | protein-energy malnutrition | Vital Pakistan Trust | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06200883 Comparator | Sep 2022 → Sep 2023 | cognitive impairment with or without cerebellar ataxia | Federico II University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Choline Bitartrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05108974 ↗ |
| Modality | Small molecule | — CHEMBL2105935 ↗ |